Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 4071-4077

  Divella, Chiara ^a   Rossini, Michele ^a   Loverre, Antonia ^a   Schena, Antonio ^a   Maiorano, Annamaria ^a   Gesualdo, Vincenzo ^a   Zaza, Gianluigi ^a   Grandaliano, Giuseppe ^a   Schena, Francesco Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Banff schema; chronic active antibody mediated rejection; chronic T cell mediated rejection; immunohistochemical markers; renal transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CD103 ANTIGEN; CD20 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 17; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHRONIC ACTIVE HUMORAL REJECTION; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC CALCINEURIN INHIBITOR TOXICITY; CHRONIC T CELL MEDIATED REJECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; GLOMERULOPATHY; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; VASCULAR DISEASE;

ADULT; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD8; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA CHAINS; INTERLEUKIN-17; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 78649498861     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq377     Document Type: Article

References (31)

1. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
2. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56: 783-793
3. Pascual M, Theruvath T, Kawai T et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590 (Pubitemid 34438820)
4. Nankivell BJ, Borrows RJ, Fung CL et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333
5. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005; 16: 3015-3026
6. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 2007; 7: 518-526
7. David-Neto E, Prado E, Beutel A et al. C4d-positive chronic rejection: a frequent entity with a poor outcome. Transplantation 2007; 84: 1391-1398
8. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allograft is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380
9. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338
10. Sund S, Reisaeter AV, Scott H et al. Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies. Clin Nephrol 2004; 62: 121-130
11. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63: 1888-1893
12. + regulatory T cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19: 2020-2026
13. Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356-365
14. Yang XO, Nurieva R, Martinez GJ et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29: 44-56
15. + regulatory T cells in humans. Proc Natl Acad Sci USA 2009; 106: 4793-4798
16. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898
17. Yuan R, El-Asady R, Liu K et al. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation. J Immunol 2005; 175: 2868-2879
18. Dahab GM, Kheriza MM, El-Beltagi HM et al. Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol 2004; 19: 78-85
19. Pontrelli P, Rossini M, Infante B et al. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy. Transplantation 2008; 85: 125-134
20. Mason DY, Cordell JL, Gaulard P et al. Immunohistological detection of human cytotoxic/suppressor T cells using antibodies to a CD8 peptide sequence. J Clin Pathol 1992; 45: 1084-1088
21. Hadley GA, Bartlett ST, Via CS et al. The epithelial cell-specific in-tegrin, CD103 (alpha E integrin), defines a novel subset of alloreac-tive CD8+ CTL. J Immunol 1997; 159: 3748-3756
22. Wang D, Yuan R, Fenq Y et al. Regulation of CD103 expression by CD8+ T cells responding to renal allografts. J Immunol 2004; 172: 214-221
23. Moseley AT, Haudenschild DR, Rose L et al. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174
24. Seemayer CA, Gaspert A, Nickeleit V et al. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568-576
25. Cosio FG, Gloor JM, Sethi S et al. Transplant glomerulopathy. Am J Transplant 2008; 8: 492-496
26. Homs S, Mansour H, Desvaux D et al. Predominant Th1 and cyto-toxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant 2009; 9: 1230-1236
27. Akalin E, Dinavahi R, Dikman S et al. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007; 2: 1261-1267
28. Akalin E, Dikman S, Murphy B et al. Glomerular infiltration by CXCR3+ ICOS+ activated T-cells in chronic allograft nephropa-thy with transplant glomerulopathy. Am J Transplant 2003; 3: 1116-1120
29. Maryniak R, First RM, Weiss MA. Transplant glomerulopathy: evolu-tionofmorphologically distinct changes. Kidney Int 1985; 27: 799-806
30. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future. Am J Transplant 2008; 8: 753-760
31. Stallone G, Infante B, Schena A et al. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 2005; 16: 3755-3762